VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Advanced Therapies Week 2022 | Addressing labor and educational gaps in the CGT industry

Michael Lehmicke, Senior Director of Science & Industry Affairs, Alliance for Regenerative Medicine, Washington, D.C., comments on the skills shortage in the cell and gene therapy (GCT) industry. Whilst people working in different companies during their career can enhance the exchange of technology and expertise, it highlights the need for additional workers across different disciplines including manufacturing, engineering and regulatory affairs. This interview took place at Advanced Therapies Week 2022.

Disclosures

Michael Lehmicke is the Senior Director of Science & Industry Affairs at Alliance for Regenerative Medicine.